Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
N-type calcium channels as novel molecular targets for preventing opioid-induced respiratory depression
FY 2019-20
Summary
"In Canada, opioid overdose is a leading cause of accidental death, with one life lost every two hours. Since 2016, there have been 12,800 deaths and the Canadian Institutes of Health Research have identified the opioid crisis as a critical health issue. Opioids are powerful pain-relievers prescribed for moderate to severe pain but they can also stop breathing, preventing oxygen from reaching the brain, which can lead to death. Therefore, there is an urgent need to find a way to block this fatal side effect while preserving their ability to relieve pain. Zebrafish are small freshwater fish with high reproductive and development rates that share 70% of their genes with humans. The brain circuits that control their breathing and their ability to respond to opioids is similar to humans. Our team has developed a way to measure the effects of opioids on breathing and pain relief in zebrafish. My research aims to use our zebrafish models to investigate how opioids stop breathing at a cellular level to find a way to exclusively block this side effect. One way that opioids may cause death is by closing calcium channels in areas of the brain that control breathing and my experimental data shows that giving zebrafish a drug that opens these channels with an opioid, blocks that effect. Using zebrafish, I plan to further investigate the role of these calcium channels to determine whether they are a good target for new opioid therapies that have no respiratory side effect, without affecting pain relief. Canada is experiencing a serious opioid epidemic, with the number of deaths rising yearly. My research aims to understand how opioids stop breathing at a cellular level to identify potential molecular targets for new opioids therapies that are safe to use, while still relieving pain."
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
429145
Name
Zaig Shenhab
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
N-type calcium channels as novel molecular targets for preventing opioid-induced respiratory depression
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Analgesia; Opioid-Induced Respiratory Depression; Safe Opioid Pain Therapies; Zebrafish
Abstract
"In Canada, opioid overdose is a leading cause of accidental death, with one life lost every two hours. Since 2016, there have been 12,800 deaths and the Canadian Institutes of Health Research have identified the opioid crisis as a critical health issue. Opioids are powerful pain-relievers prescribed for moderate to severe pain but they can also stop breathing, preventing oxygen from reaching the brain, which can lead to death. Therefore, there is an urgent need to find a way to block this fatal side effect while preserving their ability to relieve pain. Zebrafish are small freshwater fish with high reproductive and development rates that share 70% of their genes with humans. The brain circuits that control their breathing and their ability to respond to opioids is similar to humans. Our team has developed a way to measure the effects of opioids on breathing and pain relief in zebrafish. My research aims to use our zebrafish models to investigate how opioids stop breathing at a cellular level to find a way to exclusively block this side effect. One way that opioids may cause death is by closing calcium channels in areas of the brain that control breathing and my experimental data shows that giving zebrafish a drug that opens these channels with an opioid, blocks that effect. Using zebrafish, I plan to further investigate the role of these calcium channels to determine whether they are a good target for new opioid therapies that have no respiratory side effect, without affecting pain relief. Canada is experiencing a serious opioid epidemic, with the number of deaths rising yearly. My research aims to understand how opioids stop breathing at a cellular level to identify potential molecular targets for new opioids therapies that are safe to use, while still relieving pain."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Zaig, Shenhab
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~